Bio-Rad to Invest in Oncocyte for Exclusive Global Transplant Monitoring Technology, Eyeing FDA Clearance and Market Expansion

Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring commercialization - Bio-R...

April 12, 2024 | Friday | News
SimBioSys Launches TumorSight Plan for Enhanced Breast Cancer Surgery Decision Support

SimBioSys®, a leading TechBio company pioneering the fusion of spatial biophysics with artificial intelligence (AI) and computational modeling to redef...

April 10, 2024 | Wednesday | News
Denovo Biopharma's Liafensine Shows Promise in Phase 2b Trial for Treatment-Resistant Depression

Denovo Biopharma LLC (Denovo), a pioneer in applying precision medicine to the development of innovative drugs, today announced positive results for its bi...

April 09, 2024 | Tuesday | News
Nucleai and GoPath Diagnostics Partner to Advance Digital Pathology with AI Integration

Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic o...

April 08, 2024 | Monday | News
Johnson & Johnson Sounds Alarm on TRC Capital Investment's Below-Market Mini-Tender Offer for Company Shares

Johnson & Johnson announced that it has received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation of Ontario, Canada to...

April 05, 2024 | Friday | News
Johnson & Johnson Expands Commitment to Advance Health Equity

Johnson & Johnson announced  that it is collaborating with more than 100 community-led health organizations supporting historically marginalized c...

April 04, 2024 | Thursday | News
Biological Dynamics Expands Adoption of ExoVerita™ Pro Under Early Access Program

“Research has shown that exosomes carry important information about human health, but studying them has proven challenging,” remarked Paul R. B...

April 03, 2024 | Wednesday | News
Agilent Technologies and UC San Diego to Establish Center of Excellence in Cellular Intelligence

Agilent Technologies , a global leader in life sciences, diagnostics, and applied chemical markets, and the University of California San Diego (UC Sa...

April 03, 2024 | Wednesday | News
Voydeya Approved as Add-On Therapy for Rare PNH Treatment in the US

Voydeya (danicopan) has been granted approval in the United States as an add-on therapy for the treatment of extravascular haemolysis (EVH) in adults diagn...

April 02, 2024 | Tuesday | News
Bora Pharmaceuticals Completes Acquisition of Upsher-Smith Laboratories, Fortifying Presence in U.S. Generics Market

Bora Pharmaceuticals Co., Ltd.  announced that it has completed the acquisition of Upsher-Smith  Laboratories, LLC. (“Upsher-Smith”),...

April 02, 2024 | Tuesday | News
Laborie Medical Technologies Corp. Invests in iO Urology's Revolutionary At-Home Uroflow Device for BPH Management

Leading diagnostic and therapeutic medical technology company Laborie Medical Technologies Corp. (Laborie) announced its investment in iO Urology, a vent...

April 01, 2024 | Monday | News
Exact Sciences and Mayo Clinic Report Promising Data on Non-Endoscopic Esophageal Cancer Screening Test

  Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, in collaboration with Mayo Clinic Compr...

March 28, 2024 | Thursday | News
Exothera Expands World-First Continuous-Batch RNA Manufacturing Solution to North America to Accelerate RNA Therapies

Game-changing continuous-batch production of RNA service removes process development and scale-up steps through automation and significantly cuts clinical ...

March 27, 2024 | Wednesday | News
Nucleus Genomics Launches to Bring Whole-Genome Sequencing to the Public

    Nucleus Genomics, a pioneering genetic testing and analysis company, announced the debut of its DNA analysis product, marking a significant...

March 26, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in